CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 539482-539636 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T65","span":{"begin":0,"end":154},"obj":"Sentence"}],"text":"Treatment-emergent adverse event (TEAE) rates for tedizolid and linezolid were 49.7% and 45.8%, and drug-related TEAEs were 20.9% and 15.8%, respectively."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T94609","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment-emergent adverse event (TEAE) rates for tedizolid and linezolid were 49.7% and 45.8%, and drug-related TEAEs were 20.9% and 15.8%, respectively."}